valsartan and hydrochlorothiazide

Generic: valsartan and hydrochlorothiazide

Labeler: macleods pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name valsartan and hydrochlorothiazide
Generic Name valsartan and hydrochlorothiazide
Labeler macleods pharmaceuticals limited
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

hydrochlorothiazide 12.5 mg/1, valsartan 80 mg/1

Manufacturer
Macleods Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 33342-074
Product ID 33342-074_a1b947a6-e356-4442-9df7-9e82b299a852
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203145
Listing Expiration 2026-12-31
Marketing Start 2013-04-19

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc] angiotensin 2 receptor blocker [epc]
Mechanism of Action
angiotensin 2 receptor antagonists [moa]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 33342074
Hyphenated Format 33342-074

Supplemental Identifiers

RxCUI
200284 200285 349353 636042 636045
UPC
0333342075109 0333342074102 0333342076106 0333342077103
UNII
0J48LPH2TH 80M03YXJ7I
NUI
N0000175359 N0000175419 M0471776 N0000000070 N0000175561

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name valsartan and hydrochlorothiazide (source: ndc)
Generic Name valsartan and hydrochlorothiazide (source: ndc)
Application Number ANDA203145 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/1
  • 80 mg/1
source: ndc
Packaging
  • 90 TABLET, FILM COATED in 1 BOTTLE (33342-074-10)
  • 1000 TABLET, FILM COATED in 1 BOTTLE (33342-074-44)
source: ndc

Packages (2)

Ingredients (2)

hydrochlorothiazide (12.5 mg/1) valsartan (80 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a1b947a6-e356-4442-9df7-9e82b299a852", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "upc": ["0333342075109", "0333342074102", "0333342076106", "0333342077103"], "unii": ["0J48LPH2TH", "80M03YXJ7I"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_set_id": ["771afba6-8769-4ea8-afec-358dba0aaefe"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (33342-074-10)", "package_ndc": "33342-074-10", "marketing_start_date": "20130419"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (33342-074-44)", "package_ndc": "33342-074-44", "marketing_start_date": "20130419"}], "brand_name": "Valsartan and Hydrochlorothiazide", "product_id": "33342-074_a1b947a6-e356-4442-9df7-9e82b299a852", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "33342-074", "generic_name": "Valsartan and Hydrochlorothiazide", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valsartan and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "VALSARTAN", "strength": "80 mg/1"}], "application_number": "ANDA203145", "marketing_category": "ANDA", "marketing_start_date": "20130419", "listing_expiration_date": "20261231"}